# TYVASO

NDC: 66302-206
Generic name: treprostinil
Labeler / Manufacturer: United Therapeutics Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INHALANT
Routes: ORAL
Marketing started: 20090814

FDA application: NDA022387

## Active ingredients

- TREPROSTINIL: 1.74 mg/2.9mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66302-206"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66302-206
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cbc31ab1-a80f-4b50-a3b1-39910b0fb609